[Reversible hypokinetic cardiomyopathy revealing severe hypocalcemia]

J C Charniot1, A Alexeeva, S Laurent

  • 1Service de cardiologie, hôpital Avicenne, 125, route de Stalingrad, 93009 Bobigny.

Archives Des Maladies Du Coeur Et Des Vaisseaux
|August 10, 2001
PubMed

Insights

Severe hypocalcemia due to primary hypoparathyroidism can cause dilated cardiomyopathy and cardiac failure. Treatment of hypocalcemia can reverse cardiac dysfunction, highlighting this biochemical abnormality as a treatable cause of heart disease.

Area of Science:

  • Cardiology
  • Endocrinology
  • Biochemistry

Background:

  • Dilated cardiomyopathy (DCM) is often idiopathic or secondary to toxins or infections.
  • Biochemical abnormalities are less common causes of DCM.
  • Primary hypoparathyroidism is a rare endocrine disorder characterized by insufficient parathyroid hormone production.

Observation:

  • A 58-year-old woman presented with new-onset cardiac failure.
  • Electrocardiogram (ECG) revealed sinus tachycardia and a prolonged QT interval (560 ms).
  • Echocardiography showed dilated hypokinetic cardiomyopathy with a reduced left ventricular ejection fraction (20%).

Findings:

  • Aetiological investigation identified severe hypocalcemia (0.66 mmol/L).
  • The hypocalcemia was attributed to primary hypoparathyroidism.
  • This biochemical abnormality was the underlying cause of the cardiac dysfunction.

Implications:

  • Primary hypoparathyroidism should be considered in the differential diagnosis of unexplained dilated cardiomyopathy.
  • Correction of hypocalcemia can lead to significant improvement or resolution of cardiac disease.
  • Early diagnosis and treatment of hypoparathyroidism can prevent irreversible cardiac damage.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Diabetic Ketoacidosis ll: Pathophysiology01:22

Diabetic Ketoacidosis ll: Pathophysiology

Diabetic ketoacidosis (DKA) is a metabolic emergency characterized by hyperglycemia, ketonemia, and metabolic acidosis. It results from severe insulin deficiency and an excess of counterregulatory hormones, leading to uncontrolled lipolysis, ketogenesis, and widespread electrolyte and fluid disturbances.Pathophysiology The central event in DKA is a profound loss of insulin action. Without insulin, glucose uptake in insulin-dependent tissues is impaired, while hepatic glucose production...